NIFTY 50▲22,147.00
151.15 (0.69%)
SENSEX▲73,088.33
599.34 (0.83%)
NIFTY BANK▲47,574.15
504.70 (1.07%)
TATA MOTORS▼963.20
-8.15 (-0.84%)
INDIAN RAILWAY FINANCE CORP▼141.00
-0.95 (-0.67%)
SUZLON ENERGY▼39.35
-1.80 (-4.37%)
TATA POWER▼428.10
-1.65 (-0.38%)
TATA STEEL▲162.10
2.05 (1.28%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▼160.70
-2.45 (-1.50%)
RELIANCE INDUSTRIES▲2,940.25
11.60 (0.40%)
RELIANCE POWER▼28.05
-0.65 (-2.26%)
HDFC BANK▲1,531.30
36.60 (2.45%)
RAIL VIKAS NIGAM▼258.45
-1.45 (-0.56%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
JIO FIN SERVICES LTD▼370.10
-8.30 (-2.19%)
ADANI POWER▼594.55
-3.55 (-0.59%)
ZOMATO▲189.20
4.00 (2.16%)
NHPC▼87.15
-2.35 (-2.63%)
INDIAN RAILWAY TOURISM CORP▼992.00
-0.95 (-0.10%)
STATE BANK OF INDIA▲750.45
5.65 (0.76%)
INDIAN OIL CORP▼166.65
-2.35 (-1.39%)
MRF▼1,29,157.65
-73.85 (-0.06%)
ITC▲424.75
5.90 (1.41%)
ADANI GREEN ENERGY▼1,770.05
-5.40 (-0.30%)
ADANI ENTERPRISES▲3,026.95
7.65 (0.25%)
JAIPRAKASH POWER VENTURES▼17.05
-0.15 (-0.87%)
ADANI PORT & SEZ▲1,310.00
14.45 (1.12%)
Medicamen Biotech Share Price
MEDICAMEQ
₹414.00-₹0.90 (-0.22%) Past YearLast updated on 19 Apr, 2024 | 03:29 PM IST
₹408.05₹424.00
LH
What’s in news?
Company overview
About
Market cap
| Open₹418.95 | Close₹414.90 |
Circuit range₹497.85 - ₹331.95 | Day range₹408.05 - ₹424.00 | Year range₹355.45 - ₹845.00 |
Volume8,466 | Avg. traded₹412.97 | Revenue (12m)₹171 Cr |
Medicamen BiotechMedicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in manufacturing of diverse range of pharmaceutical products oral solids, oral liquids, ointment for non-oncology products range and also produces tablets, capsule/lyohilized/dry powder injections for oncology product range. It focuses on oncology therapeutics, and other generics. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company primarily focuses on oncology therapeutics. It is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, and Pazopanib.
Read more
Medicamen Biotech Key indicators
52 week high₹845.00 | 52 week low₹355.45 | P/E ratio42.65 |
P/B ratio2.66 | ROE9.17% | ROCE10.95% |
Dividend yield0.24% | Debt/Equity ratio0.14 | EPS11.86 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin19.64% | Net profit margin10.88% |
ROE9.17% | ROA6% |
ROCE10.95% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Medicamen Biotech Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Apr 19 2024 | ₹418.95 | ₹417.20 | -0.42% |
Thu, Apr 18 2024 | ₹420.00 | ₹414.90 | -1.23% |
Tue, Apr 16 2024 | ₹417.40 | ₹417.85 | |
Mon, Apr 15 2024 | ₹425.00 | ₹415.85 | -2.20% |
Fri, Apr 12 2024 | ₹438.40 | ₹428.85 | -2.23% |
Wed, Apr 10 2024 | ₹439.35 | ₹436.10 | -0.75% |
Tue, Apr 9 2024 | ₹444.50 | ₹430.65 | -3.22% |
Mon, Apr 8 2024 | ₹448.05 | ₹435.85 | -2.80% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 20 Sep 2023
Dividend • ₹1/share
Ex date 19 Sep 2022
Learn more